Etanercept-Induced Systemic Lupus Erythematosus in a Patient with Rheumatoid Arthritis
Tumor necrosis factor (TNF) is known to play a critical role in the pathogenesis of rheumatoid arthritis (RA). Etanercept is a recombinant soluble fusion protein of TNFα type II receptor and IgG, which acts as a specific TNF-α antagonist. Anti-TNF-α therapy has been an important advance in the treat...
| Main Authors: | , , |
|---|---|
| Format: | Online |
| Language: | English |
| Published: |
The Korean Academy of Medical Sciences
2006
|
| Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2722012/ |